DENVER, Feb. 15, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its fourth quarter and full-year 2016 financial results on Friday, March 3, 2017, before the opening of the U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and Jeffrey M. Kreger, Senior Vice President, Chief Financial Officer and Treasurer, will conduct a conference call as follows:
| Date |
|
Friday, March 3, 2017 |
| Time |
|
9:00 a.m. EST |
| Toll free (U.S.) |
|
(888) 372-9592 |
| Webcast (live and replay) |
|
www.bioscrip.com |
| |
|
|
A replay of the conference call will be available for one week after the call's completion by dialing (855) 859-2056 (US) and entering conference call ID number 5266355.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion and home healthcare management solutions. BioScrip partners with healthcare providers, including physicians, hospital systems, skilled nursing facilities, and with healthcare payors to provide patients better access to high quality, efficient post-acute care services. BioScrip operates with a commitment to bring infusion therapy services into the home or alternate-site settings. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Investor Contacts:
Jeffrey M. Kreger
Chief Financial Officer
T: (720) 697-5200
jeffrey.kreger@bioscrip.com
David ClairICR, Inc.
T: (646) 277-1266
david.clair@icrinc.com
Bioscrip, Inc.
